Table 1.
Age (years) | Value (%) |
---|---|
Range | 48 to 75 |
Mean | 60.6 |
Gender | |
Male | 6 (75) |
Female | 1 (12.5) |
Unknown | 1 (12.5) |
Tumor Site | |
Oral cavity | 3 (37.5) |
Oropharynx | 4 (50) |
Unknown | 1 (12.5) |
Clinical stage | |
T1 | 3 (37.5) |
T2 | 3 (37.5) |
T3 | 1 (12.5) |
Unknown | 1 (12.5) |
Nodal status | |
N0 | 1 (12.5) |
N1 | 4 (50) |
N2 | 2 (25) |
Unknown | 1 (12.5) |
HPV status/P16 status | |
Negative | 3 (37.5) |
Positive | 3 (37.5) |
Unknown | 2 (25) |
Smoking | |
Yes (≥10 pack years) | 4 (50) |
No (<10 pack years) | 3 (37.5) |
Unknown | 1 (12.5) |
Alcohol use | |
Yes (≥5 drinks/week) | 2 (25) |
No (<5 drinks/week) | 4 (50) |
Unknown | 2 (25) |
HNSCC patients (n = 8) were enrolled in the study. Clinical stage from T1 to T3 refers to the size/extent of the tumors. Nodal status depicts the involvement of lymph nodes depending on their number and location.